Electrophoresis Reagents Market - By Type, By Technique, By End Use & Forecast, 2023

List of Tables

Electrophoresis Reagents Market is set to record more than 5% CAGR from 2023 to 2032, driven by extensive application in pharmaceutical development.

The pharmaceutical sector heavily relies on electrophoresis techniques and associated reagents for multiple critical purposes. Some of these include ensuring the quality and purity of drug formulations through meticulous quality control, conducting precise protein analysis essential for biopharmaceutical and monoclonal antibody development, and supporting nucleic acid research crucial for genetic studies and nucleic acid-based therapeutics.

In response to the escalating end-user requirements, industry players are actively introducing innovative products and solutions. For instance, in March 2023, MP Biomedicals, LLC, a leading provider of life science research products, announced the launch of new proteomic assay specialty reagents for protein staining and western blotting to its inventory.

The electrophoresis reagents market is bifurcated based on type, technique, end-use, and region.

With respect to type, the electrophoresis reagents market from the buffers segment is expected to witness notable growth from 2023-2032 owing to extensive usage in laboratories and research institutions for various molecular biology techniques, including DNA sequencing and protein electrophoresis. Lately, clinical laboratories are relying on electrophoresis for diagnostic purposes, such as serum protein analysis and hemoglobinopathy screening, further driving the adoption of buffers for precise and reliable tests.

Based on end-use, the market size from the clinical diagnostics segment is estimated to grow from 2023-2032, driven by the increasing demand for electrophoresis techniques to separate and analyze biomolecules. Electrophoresis techniques coupled with specialized reagents enable laboratories to offer broader range of diagnostic services for meeting the evolving healthcare demands of the growing global population. Furthermore, the clinical diagnostics sector is continually expanding its test menu to include more complex and comprehensive analyses.

Regionally, the Asia Pacific electrophoresis reagents market size is projected to expand at appreciable CAGR from 2023-2032. The ongoing investments in healthcare infrastructure and R&D activities have heightened the need for electrophoresis reagents to cater to various applications, including clinical diagnostics, pharmaceutical research, and life sciences. Additionally, the presence of thriving industrial sector, including manufacturing, metals, and mining has led to the growing demand for precise elemental analysis, further augmenting the regional industry outlook.

Product Code: 6171

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimations & working
1.3 Forecast calculation
- 1.3.1 COVID-19 impact on forecast, by region
  - 1.3.1.1 North America
  - 1.3.1.2 Europe
  - 1.3.1.3 Asia Pacific
  - 1.3.1.4 Latin America
  - 1.3.1.5 Middle East & Africa
1.4 Data Sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid Sources
  - 1.4.2.2 Public Sources

Chapter 2 Executive Summary

2.1 Electrophoresis reagents industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Type trends
2.4 Technique trends
2.5 End-use trends
2.6 Regional trends

Chapter 3 Electrophoresis Reagents Industry Insights

3.1 Industry ecosystem analysis
- 3.1.1 Distribution channel analysis trends
- 3.1.2 Vendor matrix
- 3.1.3 COVID-19 impact on value chain
3.2 Raw material outlook
3.3 Regulatory landscape
- 3.3.1 North America
- 3.3.2 Europe
- 3.3.3 Asia Pacific
- 3.3.4 Latin America
- 3.3.5 Middle East & Africa
3.4 Technology landscape
3.5 Pricing analysis, by region
- 3.5.1 North America
- 3.5.2 Europe
- 3.5.3 Asia Pacific
- 3.5.4 Latin America
- 3.5.5 Middle East & Africa
3.6 Cost structure Analysis
3.7 Industry impact forces
- 3.7.1 Growth drivers
- 3.7.2 Industry pitfalls and challenges
3.8 Innovation & sustainability
3.9 Growth potential analysis
3.10 Porter's analysis
- 3.10.1 Supplier power
- 3.10.2 Buyer's power
- 3.10.3 Threat of new entrants
- 3.10.4 Threat of substitutes
3.11 PESTEL analysis
3.12 Impact of COVID-19 on industry
3.13 Impact of Russia Ukraine war on the industry

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Global company market share, 2022
4.3 Company market share, by region, 2022
- 4.3.1 North America
- 4.3.2 Europe
- 4.3.3 APAC
- 4.3.4 LATAM
- 4.3.5 MEA
4.4 Competitive analysis of market player
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix

Chapter 5 Electrophoresis Reagents Market Size and Forecast, By Type 2018 - 2032

5.1 Key trends, by type
5.2 Gels
5.3 Buffers
5.4 Stains & dyes
5.5 Markers & ladders

Chapter 6 Electrophoresis Reagents Market Size and Forecast, By Technique 2018 - 2032

6.1 Key trends, by technique
6.2 Gel electrophoresis
6.3 Capillary electrophoresis

Chapter 7 Electrophoresis Reagents Market Size and Forecast, By End Use 2018 - 2032

7.1 Key trends, by end use
7.2 Life sciences & biotechnology
7.3 Clinical diagnostics
7.4 Pharmaceutical & biopharmaceutical
7.5 Academic & research institutions

Chapter 8 Electrophoresis Reagents Market Size and Forecast, By Region 2018 - 2032

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Russia
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Malaysia
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
8.6 MEA
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE

Chapter 9 Company Profiles

9.1 Thermo Fisher Scientific Inc.
9.2 Bio-Rad Laboratories, Inc.
9.3 Merck KGaA (Merck Millipore)
9.4 Agilent Technologies, Inc.
9.5 GE Healthcare
9.6 Sigma-Aldrich Corporation
9.7 Lonza Group Ltd.
9.8 Promega Corporation
9.9 Takara Bio Inc.
9.10 QIAGEN N.V.
9.11 Danaher Corporation (Cytiva)
9.12 Promega Corporation
9.13 QIAGEN N.V.
9.14 Analytik Jena AG
9.15 Expedeon Ltd.